Go Pro

Passage Bio (PASG) Earnings Date, Estimates & Call Transcripts

Passage Bio logo
$4.44 -0.04 (-0.89%)
As of 08/21/2026 04:00 PM Eastern

Passage Bio Earnings Summary

Passage Bio posted Q2 2026 earnings on August 10, 2026, reporting an EPS of -$2.44, which met the consensus estimate of -$2.44. With a trailing EPS of -$11.32, Passage Bio's earnings are expected to decrease next year, from ($9.19) to ($9.72) per share.

Upcoming Q3
Earnings Date
Nov. 9Before Market OpensEstimated
Consensus EPS
(Aug. 10)
-$2.44
Actual EPS
(Aug. 10)
-$2.44

Q2 2026 Earnings Resources

PASG Upcoming Earnings

Passage Bio's next earnings date is estimated for Monday, November 9, 2026, based on past reporting schedules.

Get Passage Bio Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Passage Bio and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

PASG Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Passage Bio Analyst EPS Estimates

Current Year EPS Consensus Estimate
($9.19) EPS
Next Year EPS Consensus Estimate
($9.72) EPS

Passage Bio Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/9/2026
(Estimated)
--------
8/10/2026Q2 2026-$2.44-$2.44--$2.44--
5/12/2026Q1 2026-$2.7640-$2.36+$0.4040-$2.36--
3/3/2026Q4 2025-$2.19-$4.08 -$1.89-$4.09--
11/10/2025Q3 2025-$2.64-$2.44+$0.20-$2.44--
8/12/2025Q2 2025-$4.00-$2.96+$1.04-$2.96--
5/13/2025Q1 2025-$4.80-$5.00 -$0.20-$0.25--
3/4/2025Q4 2024-$4.20-$4.00+$0.20-$0.20--

Passage Bio Earnings - Frequently Asked Questions

Passage Bio has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 9th, 2026 based off last year's report dates. Learn more on PASG's earnings history.

In the previous quarter, Passage Bio (NASDAQ:PASG) reported ($2.44) earnings per share (EPS) to hit the analysts' consensus estimate of ($2.44). Learn more on analysts' earnings estimate vs. PASG's actual earnings.

Passage Bio (NASDAQ:PASG) has a recorded net income of -$45.52 million. PASG has generated -$11.32 earnings per share over the last four quarters.

Passage Bio's earnings are expected to decrease from ($9.19) per share to ($9.72) per share in the next year.


Earnings data for NASDAQ:PASG is sourced from Fiscal.ai, with the most recent quarter reported on 8/10/2026. New results are added as companies report their earnings.
From Our Partners